NSC Biotech Venture Fund I LLC — Form D
NSC Biotech Venture Fund I LLC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-09. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Investing.
Offering
- Filed: 2015-03-09
- Form: D
- Accession: 0001635884-15-000001
- Industry: Investing
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Minimum investment: $25K
- Investors: 88
- Date of first sale: 2015-02-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-235439
Issuer
- Name: NSC Biotech Venture Fund I LLC
- CIK: 0001635884
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 410 PARK AVENUE, 14TH FLOOR, NEW YORK, NY, 10022
- Phone: 2123802819
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Mark Anthony Goldwasser | Executive Officer | New York, NY |
| Michael Anthony Mullen | Executive Officer | New York, NY |
More